CIK 0001894525 · <br>Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851099700
- Phone
- 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- 8-K/A Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
Page 2 of 2 · 31 filings